| 1/5 | US=23-E / Câncer Fiegl M, Mayer J. Pretreated chronic lymphocytic leukemia: use of alemtuzumab. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 343-58. ISBN 978-90-481-2917-1. LEUCEMIA CRONICA. TRATAMENTO; LINFOCITICA; TRATAMENTO COM USO DE ALEMTUZUMAB |
| 2/5 | US=14 / Dermatologia Geissler EK. Immunosuppression. In: Ulrich ESC, Euvrard S, Proby C, Bavinck JNB, Geissler EK. Skin cancer after organ transplantation. New York: Springer, 2009. p. 23-43. (Cancer Treatment and Reseach) ISBN 978-0-387-78573-8. CANCER DE PELE; TRANSPLANTE; IMUNOSSUPRESSAO; IMUNOSSUPRESSAO DE TRANSPLANTES. HISTORICO; IMUNOSSUPRESSAO FARMACOLOGICA; INIBIDORES DA CALCINEURINA; ACIDO MICOFENOLICO; INIBIDOR DE MTOR; AZATIOPRINA; CORTICOSTEROIDE; FTY720; OKT3; TIMOGLOBULINA; INTERLEUCINA-2 (IL-2); ALEMTUZUMAB; CAMPATH-1H |
| 3/5 | US=11-B / Quimioterapia Ozer H, Kurkjian C. Biologic response modifiers: principles of biotherapy. In: Perry MC. The chemotherapy source book. 4th ed. Philadelphia: Wolters Kluwer, 2008. p. 53-64. ISBN 978-0-7817-7328-7. MODIFICADORES DA RESPOSTA BIOLOGICA; BIOTERAPIA; INTERFERON; LEUCEMIA MIELOGENA CRONICA; LEUCEMIA DE CELULAS PILOSAS; CARCINOMA DE CELULAS RENAIS; MELANOMA; INTERLEUKIN-2; FATOR DE NECROSE TUMORAL; ANTICORPOS MONOCLONAIS; RITUXIMABE; TRASTUZUMABE; GEMTUZUMAB OZOGAMICINA; ALEMTUZUMAB; CETUXIMABE; BEVACIZUMABE |
| 4/5 | US=69 / Câncer Tsimberidou AM, Keating MJ. Targeted therapy in chronic lymphocytic leukemia. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 61-86. ISBN 978-1-60327-423-4. TERAPIA-ALVO EM LEUCEMIA LINFOCITICA CRONICA; CLL; PROGNOSTICO; TERAPIA; ALVO; FASE I; FLUDARABINA; ALEMTUZUMAB; RITUXIMAB; LENALIDOMIDA; TERAPIA GENETICA |
| 5/5 | US=7 / Transplante Pollinger HS, Burns JM, Casingal VP, Gores PF. The basic biology of cell therapy: current immunosuppressive drugs and clinical use. In: Halberstadt C, Emerich D, editors. Cellular transplantation: from laboratory to clinic. Amsterdam: Elsevier, 2007. p. 13-28. ISBN 978-0-12-369415-7. TERAPIA CELULAR; BIOLOGIA BASICA; DROGAS IMUNOSSUPRESSORAS; RESPOSTA ALOIMUNE; AZATIOPRINA; CICLOSPORINA; TACROLIMUS; SIROLIMUS; MICOFENOLATO DE MOFETIL; CORTICOSTEROIDES; DROGAS PROTEICAS; ANTI-SOROS POLICLONAIS; ANTICORPOS MONOCLONAIS; ANTI-CD-3; ANTI-CD-25; ANTI-CD-20; ALEMTUZUMAB; INIBIDORES DE CO-ESTIMULACAO; DESOXISPERGUALINA |